Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Genworth Financial
GNW
$3.76B
| $15.5M | 0.01% |
5,660,946
-8,987,521
| -61% | -$22.8M |
|
1902
Heritage Financial
HFWA
$1.22B
| $15.4M | 0.01% |
878,930
+131,600
| +18% | +$2.32M |
|
1903
Gold Fields
GFI
$29B
| $15.4M | 0.01% |
3,912,139
+1,469,437
| +60% | +$5.49M |
|
|
HZNP
1904
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $15.4M | 0.01% |
927,920
-1,091,348
| -54% | -$19.1M |
|
|
TWC
1905
PUT
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $15.3M | 0.01% |
75,000
-96,200
| -56% | -$18.2M |
|
|
DNKN
1906
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $15.3M | 0.01% |
325,075
+26,405
| +9% | +$1.13M |
|
1907
PUT
Phillips 66
PSX
$84.9B
| $15.3M | 0.01% |
177,000
+113,400
| +178% | +$9.22M |
|
1908
PUT
United States Oil Fund
USO
$2.15B
| $15.3M | 0.01% |
197,500
-414,688
| -68% | -$31M |
|
1909
CALL
Colgate-Palmolive
CL
$73.1B
| $15.3M | 0.01% |
216,600
-256,700
| -54% | -$17.1M |
|
1910
Cullen/Frost Bankers
CFR
$10.3B
| $15.3M | 0.01% |
277,547
+54,902
| +25% | +$2.84M |
|
1911
Southern Copper
SCCO
$143B
| $15.2M | 0.01% |
592,483
-137,677
| -19% | -$3.26M |
|
1912
CALL
Incyte
INCY
$24.2B
| $15.2M | 0.01% |
210,000
-352,300
| -63% | -$26.3M |
|
|
1913
PUT
Incyte
INCY
$24.2B
| $15.2M | 0.01% |
210,000
+200,000
| +2,000% | +$14.9M |
|
1914
Patterson-UTI
PTEN
$3.98B
| $15.2M | 0.01% |
863,439
-116,608
| -12% | -$1.74M |
|
1915
PUT
Stratasys
SSYS
$679M
| $15.2M | 0.01% |
586,600
+109,600
| +23% | +$2.23M |
|
1916
CALL
Enterprise Products Partners
EPD
$82.3B
| $15.1M | 0.01% |
615,200
+418,300
| +212% | +$9.74M |
|
1917
Bio-Rad Laboratories Class A
BIO
$8.71B
| $15.1M | 0.01% |
110,553
+29,932
| +37% | +$3.93M |
|
|
SNI
1918
CALL
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $15.1M | 0.01% |
+230,000
| New | +$13.7M |
|
1919
State Street SPDR S&P Transportation ETF
XTN
$387M
| $15M | ﹤0.01% |
326,352
-114,888
| -26% | -$4.79M |
|
1920
iShares MSCI Australia ETF
EWA
$1.39B
| $15M | ﹤0.01% |
775,008
+319,682
| +70% | +$5.75M |
|
1921
PUT
Altria Group
MO
$114B
| $14.9M | ﹤0.01% |
238,300
+70,200
| +42% | +$4.24M |
|
1922
Invesco S&P 500 Pure Growth ETF
RPG
$2.01B
| $14.9M | ﹤0.01% |
939,595
+861,985
| +1,111% | +$12.9M |
|
|
HZNP
1923
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $14.9M | ﹤0.01% |
900,000
-22,200
| -2% | -$388K |
|
1924
PUT
Diageo
DEO
$49B
| $14.9M | ﹤0.01% |
137,900
+93,600
| +211% | +$9.9M |
|
1925
CALL
PayPal
PYPL
$48.9B
| $14.9M | ﹤0.01% |
384,900
-682,200
| -64% | -$24.7M |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.